1. Home
  2. PMAX vs VVOS Comparison

PMAX vs VVOS Comparison

Compare PMAX & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Max Limited

PMAX

Powell Max Limited

SELL

Current Price

$0.75

Market Cap

3.2M

Sector

N/A

ML Signal

SELL

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.09

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMAX
VVOS
Founded
2019
2016
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
2.6M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
PMAX
VVOS
Price
$0.75
$0.09
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $1.93
AVG Volume (30 Days)
863.7K
★ 1.6M
Earning Date
11-24-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.76
EPS
★ N/A
N/A
Revenue
N/A
★ $17,443,000.00
Revenue This Year
N/A
$24.92
Revenue Next Year
N/A
$56.44
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.05
52 Week Low
$0.20
$0.09
52 Week High
$4.81
$2.69

Technical Indicators

Market Signals
Indicator
PMAX
VVOS
Relative Strength Index (RSI) 51.08 22.35
Support Level $0.24 N/A
Resistance Level $1.09 $0.36
Average True Range (ATR) 0.12 0.01
MACD 0.04 -0.00
Stochastic Oscillator 46.27 4.91

Price Performance

Historical Comparison
PMAX
VVOS

About PMAX Powell Max Limited

Powell Max Ltd operates as a financial communications platform supporting listed companies and IPO applicants throughout the capital markets lifecycle. Substantially all of the company's revenue is generated from Hong Kong. The group focused on supporting the disclosure, reporting, and transaction needs of corporate clients and their advisors. Its mission is to combine industry knowledge, execution capabilities, and a commitment to service to deliver accurate, timely, and reliable solutions for customers.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: